Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Pardes Biosciences Q4 EPS $(0.41) Beats $(0.50) Estimate

Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.50) by 18 percent. This is a 26.79 percent increase over losses of $(0.56) per share from

byBenzinga Newsdesk

March 14, 2023

1 minute read

Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.50) by 18 percent. This is a 26.79 percent increase over losses of $(0.56) per share from the same period last year.